Published in Stem Cells Transl Med on May 03, 2012
Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems. Cell Tissue Bank (2013) 1.21
Adult stem cell therapies walk the line. Nat Biotechnol (2012) 1.03
Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: a systematic review. BMC Musculoskelet Disord (2014) 0.91
Effects of Aging and Hypercholesterolemia on Oxidative Stress and DNA Damage in Bone Marrow Mononuclear Cells in Apolipoprotein E-deficient Mice. Int J Mol Sci (2013) 0.86
Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatr Crit Care Med (2015) 0.85
Renovascular hypertension leads to DNA damage and apoptosis in bone marrow cells. DNA Cell Biol (2013) 0.82
Cell therapy demonstrates promise for acute respiratory distress syndrome - but which cell is best? Stem Cell Res Ther (2013) 0.75
Andalusian initiative for advanced therapies: fostering synergies. Stem Cells Transl Med (2013) 0.75
Regulation of the microenvironment for cardiac tissue engineering. Regen Med (2017) 0.75
When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes. Haematologica (2013) 0.75
Biohybrid cochlear implants in human neurosensory restoration. Stem Cell Res Ther (2016) 0.75
Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction. J Am Heart Assoc (2017) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 13.84
Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med (2005) 12.03
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res (2001) 8.62
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest (2001) 7.20
Evidence for circulating bone marrow-derived endothelial cells. Blood (1998) 6.15
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci (2004) 4.76
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation (2005) 4.49
Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation (2001) 4.01
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95
Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res (2000) 3.64
Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation (2001) 3.50
Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med (1957) 3.40
Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res (2011) 3.23
Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol (2001) 3.04
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest (2003) 2.89
A side order of stem cells: the SP phenotype. Stem Cells (2006) 2.73
CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun (2006) 2.54
Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation (2003) 2.42
Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv (2011) 2.18
Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol (2006) 2.01
Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J Invest Dermatol (2006) 1.64
Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv (2011) 1.63
[Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function]. Rev Esp Cardiol (2007) 1.60
Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia (2005) 1.51
Evidence that very small embryonic-like stem cells are mobilized into peripheral blood. Stem Cells (2008) 1.50
Clinical translation of stem cell therapies: a bridgeable gap. Cell Stem Cell (2010) 1.29
Evidence for the hemangioblast. Exp Hematol (2005) 1.20
Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res (2010) 1.16
Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev (2008) 1.10
The bone marrow-cardiac axis: role of endothelial progenitor cells in heart failure. Eur J Cardiothorac Surg (2011) 0.99
Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. Blood (2002) 0.98
Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J Mol Cell Cardiol (2007) 0.93
Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy. Front Biosci (Elite Ed) (2011) 0.90
Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans. J Thorac Cardiovasc Surg (2006) 0.89
Plasticity after allogeneic hematopoietic stem cell transplantation. Biol Chem (2008) 0.89
Simultaneous expression of Oct4 and genes of three germ layers in single cell-derived multipotent adult progenitor cells. Ann Hematol (2008) 0.83
Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood. Ann Hematol (2010) 0.80
Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology (2008) 2.90
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum (2009) 2.38
Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A (2009) 1.43
Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy. Mol Ther (2007) 1.01
Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta. Circulation (2003) 0.97
When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes. Haematologica (2013) 0.75
Human mesenchymal stromal cell lysates as a novel strategy to recover liver function. Regen Med (2015) 0.75